4-butyrolactone has been researched along with cyc 202 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Eskin, A; Sankrithi, N | 1 |
| Hayashi, K; Matsumoto, Y; Nishida, E | 1 |
| Faerge, I; Hyttel, P; Mayes, M; Sirard, MA | 1 |
| Crotti, G; Galli, C; Lagutina, I; Lazzari, G; Ponderato, N; Turini, P | 1 |
| Choi, YH; Hinrichs, K; Love, CC; Reinoehl, C; Varner, DD; Wiggins, CN | 1 |
| Crotti, G; Duchi, R; Galli, C; Lazzari, G; Ponderato, N; Turini, P | 1 |
| Boland, M; Faerge, I; Fair, T; Hyttel, PM; Lonergan, P | 1 |
| Le Beux, G; Richard, FJ; Sirard, MA | 1 |
| Juang, JL; Lin, H; Wang, PS | 1 |
| Beaman-Hall, CM; Mathur, A; Monaco, EA; Vallano, ML | 1 |
| Donnay, I; Faerge, I; Galli, C; Grøndahl, C; Lazzari, G; Ponderato, N; Sayoud, H; Verhaeghe, B | 1 |
| Adona, PR; Lima Verde Leal, C | 1 |
| Adona, PR; Leal, CL; Pires, PR; Quetglas, MD; Schwarz, KR | 1 |
| Hanna, C; Kraemer, D; Long, CR; Menges, S | 1 |
| Jin, X; Kong, X; Li, G; Liu, T; Wang, L | 1 |
| Guaitolini, CR; Guastali, MD; Kievitsbosch, T; Landim-Alvarenga, FC; Maziero, RR; Moraes, CN; Paschoal, DM | 1 |
| Crespilho, AM; Guaitolini, CRF; Landim-Alvarenga, FDC; Lima, JS; Maziero, RRD; Monteiro, BA; Paschoal, DM; Sestari, DAO | 1 |
17 other study(ies) available for 4-butyrolactone and cyc 202
| Article | Year |
|---|---|
Effects of cyclin-dependent kinase inhibitors on transcription and ocular circadian rhythm of Aplysia.
Topics: 4-Butyrolactone; Action Potentials; Animals; Aplysia; Circadian Rhythm; Cyclin-Dependent Kinases; Electrophysiology; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Kinetin; Macromolecular Substances; Neural Conduction; Ocular Physiological Phenomena; Purines; RNA, Messenger; Roscovitine; Transcription, Genetic | 1999 |
Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.
Topics: 4-Butyrolactone; Animals; CDC2-CDC28 Kinases; Cell Cycle; Centrosome; CHO Cells; Cricetinae; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; G1 Phase; Gene Expression; Hydroxyurea; Mimosine; Protein Serine-Threonine Kinases; Purines; Roscovitine; S Phase | 1999 |
Nuclear ultrastructure in bovine oocytes after inhibition of meiosis by chemical and biological inhibitors.
Topics: 4-Butyrolactone; Adenine; Animals; Antineoplastic Agents; Cattle; Cell Nucleolus; Cell Nucleus; Cells, Cultured; Cycloheximide; Enzyme Inhibitors; Female; Meiosis; Microscopy, Electron; Nuclear Envelope; Oocytes; Protein Synthesis Inhibitors; Purines; Roscovitine | 2001 |
Bovine oocytes treated prior to in vitro maturation with a combination of butyrolactone I and roscovitine at low doses maintain a normal developmental capacity.
Topics: 4-Butyrolactone; Animals; Cattle; Cell Nucleus; Drug Synergism; Embryo, Mammalian; Embryonic and Fetal Development; Female; Freezing; In Vitro Techniques; Meiosis; Oocytes; Purines; Roscovitine; Survival Rate; Time Factors | 2001 |
Suppression of meiosis by inhibitors of m-phase proteins in horse oocytes with low meiotic competence.
Topics: 4-Butyrolactone; Adenine; Animals; Chromatin; Dimethyl Sulfoxide; Horses; Meiosis; Oocytes; Oogenesis; Purines; Roscovitine | 2002 |
Embryonic and foetal development of bovine oocytes treated with a combination of butyrolactone I and roscovitine in an enriched medium prior to IVM and IVF.
Topics: 4-Butyrolactone; Animals; Cattle; Drug Interactions; Embryonic and Fetal Development; Fertilization in Vitro; Freezing; Oocytes; Purines; Roscovitine | 2002 |
Ultrastructural modifications in bovine oocytes maintained in meiotic arrest in vitro using roscovitine or butyrolactone.
Topics: 4-Butyrolactone; Animals; Cattle; Cell Nucleus; Enzyme Inhibitors; Growth Inhibitors; Meiosis; Oocytes; Purines; Roscovitine; Zona Pellucida | 2003 |
Effect of cycloheximide, 6-DMAP, roscovitine and butyrolactone I on resumption of meiosis in porcine oocytes.
Topics: 4-Butyrolactone; Adenine; Animals; Cells, Cultured; Cyclin-Dependent Kinases; Cycloheximide; Enzyme Inhibitors; Female; Meiosis; Oocytes; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Purines; Roscovitine; Swine | 2003 |
Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis.
Topics: 4-Butyrolactone; Apoptosis; Calcium; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Digoxin; Dipeptides; Enzyme Activation; Enzyme Inhibitors; Humans; Male; Nerve Tissue Proteins; Prostatic Neoplasms; Purines; RNA, Small Interfering; Roscovitine | 2004 |
Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons.
Topics: 4-Butyrolactone; Animals; Apoptosis; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cerebellum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinases; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Kinetin; Mitogen-Activated Protein Kinases; Neurons; Phosphorylation; Proto-Oncogene Proteins; Purines; Pyrimidines; Rats; Rats, Sprague-Dawley; Roscovitine; Signal Transduction; Sulfonamides | 2004 |
Effect of prematuration, meiosis activating sterol and enriched maturation medium on the nuclear maturation and competence to development of calf oocytes.
Topics: 4-Butyrolactone; Animals; Cattle; Cell Nucleus; Culture Media; Cytoplasm; Embryonic and Fetal Development; Female; Fertilization in Vitro; Follicular Fluid; Glutathione; Growth Inhibitors; Meiosis; Oocytes; Ovarian Follicle; Purines; Roscovitine; Sterols | 2004 |
Meiotic inhibition with different cyclin-dependent kinase inhibitors in bovine oocytes and its effects on maturation and embryo development.
Topics: 4-Butyrolactone; Animals; Cattle; Cyclin-Dependent Kinases; Embryo, Mammalian; Meiosis; Oocytes; Purines; Roscovitine | 2004 |
Nuclear maturation kinetics and in vitro embryo development of cattle oocytes prematured with butyrolactone I combined or not combined with roscovitine.
Topics: 4-Butyrolactone; Animals; Cattle; Cell Culture Techniques; Culture Media; Embryonic Development; Female; Fertilization in Vitro; Male; Oocytes; Pregnancy; Protein Kinase Inhibitors; Purines; Roscovitine | 2008 |
Synchronisation of canine germinal vesicle stage oocytes prior to in vitro maturation alters the kinetics of nuclear progression during subsequent resumption of meiosis.
Topics: 4-Butyrolactone; Animals; Antimitotic Agents; Cell Culture Techniques; Cell Nucleus; Cells, Cultured; Dogs; Drug Combinations; Estradiol; Female; Gonadotropins, Equine; Meiosis; Oocyte Retrieval; Oocytes; Oogenesis; Purines; Roscovitine | 2008 |
Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats.
Topics: 4-Butyrolactone; Animals; Antidepressive Agents; Chromones; Cyclin-Dependent Kinase 5; Depression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Helplessness, Learned; Hippocampus; Indoles; Male; Maleimides; Morpholines; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2014 |
Effect of Temporary Meiotic Attenuation of Oocytes with Butyrolactone I and Roscovitine in Resistance to Bovine Embryos on Vitrification.
Topics: 4-Butyrolactone; Animals; Apoptosis; Cattle; Cell Cycle Checkpoints; Drug Therapy, Combination; Embryo Culture Techniques; Meiosis; Protein Kinase Inhibitors; Purines; Roscovitine | 2016 |
Treatment with roscovitine and butyrolactone I prior to
Topics: 4-Butyrolactone; Animals; Blastocyst; Cattle; Embryo, Mammalian; Female; Fertilization in Vitro; In Vitro Oocyte Maturation Techniques; Meiosis; Oocytes; Protein Kinase Inhibitors; Roscovitine | 2020 |